Journal
BLOOD
Volume 113, Issue 8, Pages 1670-1680Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-05-156752
Keywords
-
Categories
Funding
- Howard Hughes Medical Institute
- NIH [1 R01 AG024945-01, 2 R01 EY013969-05, CA46592]
- American Heart Association [0725726Z]
- Cancer Research Institute
- University of Michigan (UM) Institute of Gerontology
- Rheumatic Core Disease Center [P30 AR48310]
Ask authors/readers for more resources
High levels of aldehyde dehydrogenase (ALDH) activity have been proposed to be a common feature of stem cells. Adult hematopoietic, neural, and cancer stem cells have all been reported to have high ALDH activity, detected using Aldefluor, a fluorogenic substrate for ALDH. This activity has been attributed to Aldh1a1, an enzyme that is expressed at high levels in stem cells and that has been suggested to regulate stem cell function. Nonetheless, Aldh1a1 function in stem cells has never been tested genetically. We observed that Aldh1a1 was preferentially expressed in mouse hematopoietic stem cells (HSCs) and expression increased with age. Hematopoietic cells from Aldh1a1-deficient mice exhibited increased sensitivity to cyclophosphamide in a non-cell-autonomous manner, consistent with its role in cyclophosphamide metabolism in the liver. However, Aldh1a1 deficiency did not affect hematopoiesis, HSC function, or the capacity to reconstitute irradiated recipients in young or old adult mice. Aldh1a1 deficiency also did not affect Aldefluor staining of hematopoietic cells. Finally, Aldh1a1 deficiency did not affect the function of stem cells from the adult central or peripheral nervous systems. Aldh1a1 is not a critical regulator of adult stem cell function or Aldefluor staining in mice. (Blood. 2009; 113: 1670-1680)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available